Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Ironwood Pharmaceuticals, Inc.    IRWD

Delayed Quote. Delayed  - 05/26 09:59:59 pm
12.23 USD   -0.33%
05/18 IRONWOOD PHARMA : to Present at 2016 UBS Global Healthcare Conferenc..
05/17 IRONWOOD PHARMA : to Present Linaclotide Data at Digestive Disease W..
05/17 IRONWOOD PHARMA : to Present Linaclotide Data at Digestive Disease W..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector news 
Most relevant news about IRONWOOD PHARMACEUTICALS,
05/18 IRONWOOD PHARMACEUTICALS : to Present at 2016 UBS Global Healthcare Conference
05/17 IRONWOOD PHARMACEUTICALS : to Present Linaclotide Data at Digestive Disease Week..
05/17 IRONWOOD PHARMACEUTICALS : to Present Linaclotide Data at Digestive Disease Week..
05/09 IRONWOOD PHARMACEUTICALS : reports 1Q loss
05/09 IRONWOOD PHARMACEUTICALS : Provides First Quarter 2016 Investor Update
05/03 IRONWOOD PHARMACEUTICALS : to Present at Bank of America Merrill Lynch 2016 Heal..
05/03 INVESTOR INVESTIGATION OF IRONWOOD P : IRWD) Concerning Potential Violations of ..
04/28 Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Ironwood Pharma..
04/28 Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ironwood Pha..
04/28 IMPORTANT SHAREHOLDER NOTICE : Goldberg Law PC Announces an Investigation of Cla..
04/27 Ironwood Pharmaceuticals & ResMed, are Worth Watching Stocks
04/27 Investigation of Ironwood Pharmaceuticals, Inc. Announced by Law Offices of H..
04/26 IRONWOOD PHARMACEUTICALS : Investigated for Potential Violations of Federal Secu..
04/26 ASTRAZENECA : and Ironwood sign Zurampic licensing agreement
04/26 ASTRAZENECA : sells U.S. gout drug rights to Ironwood for up to $265 million
More most relevant news
All news about IRONWOOD PHARMACEUTICALS,
05/18 IRONWOOD PHARMACEUTICALS : to Present at 2016 UBS Global Healthcare Conference
05/17 IRONWOOD PHARMACEUTICALS : to Present Linaclotide Data at Digestive Disease Week..
05/17 IRONWOOD PHARMACEUTICALS : to Present Linaclotide Data at Digestive Disease Week..
05/12 IRONWOOD PHARMACEUTICALS : to Present at Bank of America Merrill Lynch 2016 Heal..
05/09 IRONWOOD PHARMACEUTICALS : reports 1Q loss
05/09 IRONWOOD PHARMACEUTICALS INC : Results of Operations and Financial Condition, Fi..
05/09 IRONWOOD PHARMACEUTICALS : Provides First Quarter 2016 Investor Update
05/05 IRONWOOD PHARMACEUTICALS : to Host First Quarter 2016 Investor Update Call
05/05 Investigation of Ironwood Pharmaceuticals, Inc. Announced by Law Offices of H..
05/05 IRONWOOD PHARMACEUTICALS : Enters into U.S. Licensing Agreement with AstraZeneca..
More news
Sector news : Biotechnology & Medical Research - NEC
05/26 ALDER BIOPHARMACEUTICALS : Continues to Strengthen and Expand Leadership Team to..
05/26DJIonis's Shares Fall After Co-Developer Opts Against Starting Late-Stage Trial
05/26 REGENERON PHARMACEUTICALS : Selected by Society for Science & the Public as New ..
05/26 REGENERON PHARMACEUTICALS : Words of Support from Public Figures on Regeneron ST..
05/26 ALKERMES : Appoints Nancy Snyderman, M.D., to Board of Directors
05/26DJSANOFI : Moves to Replace Medivation's Board -- WSJ
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
05/09 Ironwood Pharmaceuticals' (IRWD) CEO Peter Hecht on Q1 2016 Results - Earning..
05/09 Ironwood Pharmaceuticals beats by $0.06, beats on revenue
05/09 Ironwood Pharma Q1 top line up 128%, loss per share improves 67%
05/08 Notable earnings after Monday?s close
04/27 UNCOVERED : Safety Issues Linked With Ironwood's Drug, Linzess
04/27 BIOTECH FORUM DAILY DIGEST : Sarepta Plunges On Ad Comm Decision, Novartis To Be..


Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials